AL 47-LEA CONGRES AL SOCIETĂȚII ROMÂNE DE ANESTEZIE ȘI TERAPIE INTENSIVĂ

AL 15-LEA CONGRES ROMÂNO-FRANCEZ DE ANESTEZIE ȘI TERAPIE INTENSIVĂ
AL 13-LEA SIMPOZION ROMÂNO-ISRAELIAN DE ACTUALITĂȚI ÎN ANESTEZIE ȘI TERAPIE INTENSIVĂ
AL 20-LEA CONGRES AL ASISTENȚILOR DE ANESTEZIE ȘI TERAPIE INTENSIVĂ
AL 8-LEA SIMPOZION "ROMÂNIA DODOLOAȚĂ" AL SOCIETĂȚILOR DE ANESTEZIE ȘI TERAPIE INTENSIVĂ DIN ROMÂNIA ȘI MOLDOVA


15 - 19 SEPTEMBRIE 2021
Eveniment virtual

Începând cu 04 septembrie (înscriere târzie)

CAN ince

Professor Can Ince is a physiologist and since 2020 heads the   Laboratory of Translational Intensive Care Medicine, Department of Intensive Care Medicine (head Prof Gommers) of the  Erasmus Medical Center Rotterdam. He is a Professor in Clinical Physiology “Cardiovascular aspects of peri-operative and intensive care medicine” . Previously he headed the Department of Translational Physiology at the Academic Medical Center (AMC) of the University of Amsterdam. The mission of his group is to accomplish bench to bedside translation of insights into pathophysiology, novel treatment modalities concepts and the development innovative diagnostic techniques relevant to critical care medicine. Together with his team he conducts both experimental and clinical research.  In his Laboratory animal experimentation and technology development occurs directed at (micro)circulation and oxygenation in intensive care, surgery and anesthesiology. One of their main interests is acute kidney injury besides other topics related to sepsis, shock and resuscitation. His main contribution to  medicine has been the development and clinical introduction of hand-held vital microscopes allowing the first-time visualization and monitoring of the microcirculation at the bedside during surgery, anesthesia and intensive care medicine gaining important insight into pathophysiology of shock, sepsis and response to therapy. He is chief scientific officer of a company called Active Medical BV (Leiden, The Netherlands) whose business is to provide services, products and software related to clinical microcirculation.

He is on the editorial boards of several journals and has organized several international conferences on intensive care related topics. He  has a H- factor of 65, holds several patents, has authored over 600  scientific peer reviewed papers as well as edited several books.